Hana Pharm Co., Ltd. (KRX:293480)

South Korea · Delayed Price · Currency is KRW

8,670.00

+10.00 (0.12%)

At close: Aug 3, 2026

Hana Pharm Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2017	FY 2016
Period Ending	Dec '17 Dec 31, 2017	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Revenue	139,331	139,331	124,535
Revenue Growth	-	11.88%	-
Gross Profit	94,003	94,003	83,676
Operating Income	31,811	31,811	23,671
Net Income	24,305	24,305	17,431
Earnings Per Share	2243.00	2243.00	2248.00
EPS Growth	-	-0.22%	-

Revenue by Geography

Fiscal Year	TTM	FY 2017	FY 2016
Period Ending	Dec '17 Dec 31, 2017	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea	139,019	139,019	124,106
Foreign	311.89	311.89	429.43
Total	139,331	139,331	124,535

Cash & Debt

Fiscal Year	Current	FY 2017	FY 2016
Period Ending	Dec '17 Dec 31, 2017	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Cash & Investments	16,490	16,490	3,159
Total Debt	29,045	29,045	30,934
Net Cash (Debt)	-12,555	-12,555	-27,775
Net Cash Growth	-	-	-
Net Cash Per Share	-1158.68	-1158.68	-3582.02

Cash Flow & CapEx

Fiscal Year	TTM	FY 2017	FY 2016
Period Ending	Dec '17 Dec 31, 2017	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Operating Cash Flow	25,380	25,380	12,464
Capital Expenditures	-10,193	-10,193	-8,310
Free Cash Flow	15,187	15,187	4,154
Free Cash Flow Growth	-	265.64%	-

Margins

Fiscal Year	TTM	FY 2017	FY 2016
Period Ending	Dec '17 Dec 31, 2017	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Gross Margin	67.47%	67.47%	67.19%
Operating Margin	22.83%	22.83%	19.01%
Pretax Margin	22.22%	22.22%	17.63%
Profit Margin	17.44%	17.44%	14.00%
FCF Margin	10.90%	10.90%	3.33%